Trial: 201602150

AAML1531 – Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome: A COG Groupwide Phase III Study

Phase

III

Principal Investigator

Hayashi, Robert

Disease Site

Acute Myeloid Leukemia (AML); Myeloid and Monocytic Leukemia; Pediatric Cancers

Learn more about this study at: clinicaltrials.gov